Process for the purification of recombinant human erythropoietin (epo), epo thus purified and pharmaceutical compositions comprising same
ZA201001654B
Liquid formulation of G-CSF
DE102009032179A1
Process for purifying interferon beta
CN104688679A
Liquid formulation of fsh
CN102037004A
Glycoconjugation of polypeptides using oligosaccharyltransferases
BRPI0813913A2
Nucleic acid molecule, recombinant nucleic acid sequence, host cell, methods for producing recombining human fsh, and for producing hostly acid sequence cell,
NZ580030A
Methods of treatment using glycopegylated g-csf
UA99454C2
Methods of treatment using glycopegylated g-csf
DE102007040932A1
Liquid granulocyte colony-stimulating factor formulation, e.g. for treating cancer, neutropenia, HIV infections or neurological disorders, comprises a sugar alcohol, surfactant and acetate buffer
EP1984013A2
Modifications of cst-ii for increased protein expression
IL167920A
Cell-free in vitro method of forming a covalent conjugate between an erythropoietin peptide and poly(ethylene glycol), pharmaceutical compositions comprising said covalent conjugate and use thereof in the preparation of medicaments for stimulating proliferation, differentiation and activation of myeloid progenitor cells
AU2005222782A1
Methods of refolding mammalian glycosyltransferases
